Baicalin regulated multiple members of the STAT family, including STAT1, STAT3, STAT4, and STAT5, for treating T2D-induced liver tumor, sepsis, and myocardial ischemia reperfusion injury (Jiang et al., 2022). The gene discussed is STAT5A; the disease is type 2 diabetes mellitus.